Our work is driven by a singular, heartfelt mission: to alleviate the suffering of cats with FIP and give them a new lease on life. This purpose fuels our scientific diligence and our quality ethos. Every decision we make—from process optimization to final release testing—is measured against its impact on patient well-being. We are not just producing pharmaceuticals; we are delivering on a promise of a second chance. At FIPRecover, we combine compassion with cutting-edge science to transform the prognosis for FIP, turning a once-hopeless diagnosis into a story of recovery and renewed joy.
A Mission-Driven Company: Giving Cats a New Lease on Life
..Our Team..
Meet Our Experts
Core R&D Team: Conquering FIP
A. Drug Development Expert Group We are a group of senior biomedical researchers, and we design drugs (such as GS441524) that specifically target the FIP virus. We optimize drug molecules to boost efficacy and reduce side effects, and we collaborate with animal hospitals to run clinical trials. Our work achieves three key goals: antiviral suppression, inflammation reduction, and improvement of fever and ascites. B. Quality Control Team We oversee the entire process: from raw materials to production to testing, and we select pharmaceutical raw materials strictly while monitoring production indicators closely. We conduct dual tests (safety and efficacy) on each batch of drugs, and these steps we take ensure the reliability of the drugs.
Treatment Support Team: Solving Problems for Owners
A. Senior Veterinarian Team We have over 5 years of treatment experience, so we provide free answers to owners’ questions like “Does my cat have FIP?” and “What’s the right dosage?” We follow up on cats’ recovery progress and give advice on their diet and complication prevention. B. Medication Guidance Specialist We (as medication guidance specialists) teach owners how to inject GS441524 and how to store it properly. We respond quickly to issues like “discomfort after medication and coordinate with veterinarians to adjust treatment plans.